PATTERNS OF MEDICINE USE FOR COVID-19 PATIENTS AT UNDATA HOSPITAL PALU

A. Rumi, N. Ambianti, Desti Sulistiani Arbi
{"title":"PATTERNS OF MEDICINE USE FOR COVID-19 PATIENTS AT UNDATA HOSPITAL PALU","authors":"A. Rumi, N. Ambianti, Desti Sulistiani Arbi","doi":"10.20473/jaki.v10i1.2022.99-110","DOIUrl":null,"url":null,"abstract":"Background: Covid-19 cases had drastically increased. Little therapy has been formulated to respond to the situation. Covid-19 symptoms in Indonesia are divided into four classes: asymptomatic, mild, moderate, and severe.\nAims: This study aims to illustrate the pattern of drug use in Covid-19 patients at Undata Palu Hospital.\nMethods: This study is a type of cross-sectional descriptive study using a cross-sectional design and collecting data retrospectively from medical records at Undata Hospital Palu in 2020.\nResults: In 2020, 186 patients were confirmed positive for Covid-19. There were 95 female patients (51.9%) and 50 patients at the age of 46-55 years (27.3%). The severe symptoms happened to 109 patients (59.6%). The most common clinical manifestation was cough in 127 patients (23.3%). The most common comorbidity was pneumonia (30.8%). The most widely used primary therapy was the antibiotic azithromycin applied to 155 patients (30.0%), and the most widely used supportive therapy was vitamin C among 141 patients (20.1%). Oseltamivir antiviral therapy was administered to 132 patients (25.6%) and remdesivir to 34 patients (6.6%).\nConclusion: Covid-19 patients were mostly treated with antibiotic therapy (41.5%), antiviral therapy (32.2%), antimalarial therapy (15.7%), and corticosteroid therapy (10.7%). As many as 132 patients took oseltamivir, and 34 patients took remdesivir. However, for now, oseltamivir is no longer used.","PeriodicalId":32968,"journal":{"name":"Jurnal Administrasi Kesehatan Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Administrasi Kesehatan Indonesia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20473/jaki.v10i1.2022.99-110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Covid-19 cases had drastically increased. Little therapy has been formulated to respond to the situation. Covid-19 symptoms in Indonesia are divided into four classes: asymptomatic, mild, moderate, and severe. Aims: This study aims to illustrate the pattern of drug use in Covid-19 patients at Undata Palu Hospital. Methods: This study is a type of cross-sectional descriptive study using a cross-sectional design and collecting data retrospectively from medical records at Undata Hospital Palu in 2020. Results: In 2020, 186 patients were confirmed positive for Covid-19. There were 95 female patients (51.9%) and 50 patients at the age of 46-55 years (27.3%). The severe symptoms happened to 109 patients (59.6%). The most common clinical manifestation was cough in 127 patients (23.3%). The most common comorbidity was pneumonia (30.8%). The most widely used primary therapy was the antibiotic azithromycin applied to 155 patients (30.0%), and the most widely used supportive therapy was vitamin C among 141 patients (20.1%). Oseltamivir antiviral therapy was administered to 132 patients (25.6%) and remdesivir to 34 patients (6.6%). Conclusion: Covid-19 patients were mostly treated with antibiotic therapy (41.5%), antiviral therapy (32.2%), antimalarial therapy (15.7%), and corticosteroid therapy (10.7%). As many as 132 patients took oseltamivir, and 34 patients took remdesivir. However, for now, oseltamivir is no longer used.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巴鲁UNDATA医院新冠肺炎患者用药模式
背景:新冠肺炎病例急剧增加。几乎没有针对这种情况制定的治疗方案。印度尼西亚的Covid-19症状分为四类:无症状、轻度、中度和重度。目的:本研究旨在说明Undata Palu医院Covid-19患者的药物使用模式。方法:本研究是一种横断面描述性研究,采用横断面设计,回顾性收集帕卢Undata医院2020年的病历数据。结果:2020年新冠肺炎确诊病例186例。其中女性95例(51.9%),46 ~ 55岁50例(27.3%)。重度症状109例(59.6%)。127例(23.3%)患者以咳嗽为主要临床表现。最常见的合并症是肺炎(30.8%)。应用最多的主要治疗是抗生素阿奇霉素(155例,占30.0%),应用最多的支持治疗是维生素C(141例,占20.1%)。132例(25.6%)患者接受奥司他韦抗病毒治疗,34例(6.6%)患者接受瑞德西韦抗病毒治疗。结论:新冠肺炎患者主要采用抗生素治疗(41.5%)、抗病毒治疗(32.2%)、抗疟治疗(15.7%)和皮质类固醇治疗(10.7%)。服用奥司他韦的患者达132例,服用瑞德西韦的患者达34例。然而,目前奥司他韦已不再使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
16
审稿时长
8 weeks
期刊最新文献
VACCINATION ATTITUDE AMONG HEALTHCARE WORKERS AT THE EARLY PHASE OF COVID-19 IN MALAYSIA SEVERAL PILLARS OF HEALTH TRANSFORMATION IN INDONESIA: FROM RESILIENCE PHARMACEUTICAL SUPPLY, HEALTH INSURANCE, PRIMARY HEATH CARE, TO DIGITAL HEALTH HAS INCLUSIVE HEALTH ACCESS IN JAKARTA'S PUBLIC HEALTH CENTER BEEN FULFILLED? DETERMINE THE TARGET TO INCREASE PRIMARY HEALTHCARE UTILIZATION IN INDONESIA'S DISADVANTAGED AREAS EARLY STRESS DETECTION DURING PREGNANCY USING E-HEALTH IN THE PANDEMIC
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1